Search results for "LSU"
showing 10 items of 384 documents
CCDC 149024: Experimental Crystal Structure Determination
2001
Related Article: A.Shivanyuk, M.Saadioui, F.Broda, I.Thondorf, M.O.Vysotsky, K.Rissanen, E.Kolehmainen, V.Bohmer|2004|Chem.-Eur.J.|10|2138|doi:10.1002/chem.200305633
CCDC 1834563: Experimental Crystal Structure Determination
2018
Related Article: Serhii Krykun, Vincent Croué, Magali Allain, Zoia Voitenko, Juan Aragó, Enrique Ortí, Sébastien Goeb, Marc Sallé|2018|J.Mater.Chem.C|6|13190|doi:10.1039/C8TC04730H
CCDC 2194827: Experimental Crystal Structure Determination
2022
Related Article: Johanna M. Alaranta, Khai-Nghi Truong, María Francisca Matus, Sami A. Malola, Kari T. Rissanen, Sailee S. Shroff, Varpu S. Marjomäki, Hannu J. Häkkinen, Tanja M. Lahtinen|2022|Dyes Pigm.|208|110844|doi:10.1016/j.dyepig.2022.110844
CCDC 1993374: Experimental Crystal Structure Determination
2020
Related Article: Felix Brosge, Johannes Florian Kochs, Mariela Bregu, Khai-Nghi Truong, Kari Rissanen, Carsten Bolm|2020|Org.Lett.|22|6667|doi:10.1021/acs.orglett.0c02504
CCDC 152579: Experimental Crystal Structure Determination
2001
Related Article: M.J.Krische, J.-M.Lehn, N.Kyritsakas, J.Fischer, E.K.Wegelius, K.Rissanen|2000|Tetrahedron|56|6701|doi:10.1016/S0040-4020(00)00489-0
Par sabiedrisko zinātni Helsus festivālā
2017
Informācija par Nacionālā atvērtās piekļuves dienesta dalību Helsus Zināšanu festivālā (Jelgavā, 2017.gada maijā) ar informācijas stendu par sabiedriskās zinātnes (citizen science) kustību. Sabiedriskā zinātne ir viens no atvērtās zinātnes konceptiem, un tā ir prakse, kuras pamatā pētniecība notiek ar sabiedrības līdzdalību.
Mutational analysis of 105 mucopolysaccharidosis type VI patients
2007
Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy syndrome) is a lysosomal storage disorder caused by mutations in the N-acetylgalactosamine-4-sulfatase (arylsulfatase B, ARSB) gene. ARSB is a lysosomal enzyme involved in the degradation of the glycosaminoglycans (GAG) dermatan and chondroitin sulfate. ARSB mutations reduce enzyme function and GAG degradation, causing lysosomal storage and urinary excretion of these partially degraded substrates. Disease onset and rate of progression is variable, producing a spectrum of clinical presentation. In this study, 105 MPS VI patients—representing about 10% of the world MPS VI population—were studied for molecular genetic and biochemical parame…
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical …
2008
Abstract The objective of this study was to evaluate the long-term clinical benefits and safety of recombinant human arylsulfatase B (rhASB) treatment of mucopolysaccharidosis type VI (MPS VI: Maroteaux-Lamy syndrome), a lysosomal storage disease. Fifty-six patients derived from 3 clinical studies were followed in open-label extension studies for a total period of 97–260 Weeks. All patients received weekly infusions of rhASB at 1mg/kg. Efficacy was evaluated by (1) distance walked in a 12-minute walk test (12MWT) or 6-minute walk test (6MWT), (2) stairs climbed in the 3-minute stair climb (3MSC), and (3) reduction in urinary glycosaminoglycans (GAG). Safety was evaluated by compliance, adve…
Determination of ethyl sulfate – a marker for recent ethanol consumption – in human urine by CE with indirect UV detection
2006
A CE method for the determination of the ethanol consumption marker ethyl sulfate (EtS) in human urine was developed. Analysis was performed in negative polarity mode with a background electrolyte composed of 15 mM maleic acid, 1 mM phthalic acid, and 0.05 mM cetyltrimethylammonium bromide (CTAB) at pH 2.5 and indirect UV detection at 220 nm (300 nm reference wavelength). This buffer system provided selective separation conditions for EtS and vinylsulfonic acid, employed as internal standard, from urine matrix components. Sample pretreatment of urine was minimized to a 1:5 dilution with water. The optimized CE method was validated in the range of 5-700 mg/L using seven lots of urine. Intra-…
Pooled analysis of who surgical safety checklist use and mortality after emergency laparotomy
2019
Background The World Health Organization (WHO) Surgical Safety Checklist has fostered safe practice for 10 years, yet its place in emergency surgery has not been assessed on a global scale. The aim of this study was to evaluate reported checklist use in emergency settings and examine the relationship with perioperative mortality in patients who had emergency laparotomy. Methods In two multinational cohort studies, adults undergoing emergency laparotomy were compared with those having elective gastrointestinal surgery. Relationships between reported checklist use and mortality were determined using multivariable logistic regression and bootstrapped simulation. Results Of 12 296 patients incl…